The National Institutes of Health (NIH) is offering this grant to support studies focusing on developing CNS-targeted drug delivery strategies to better suppress HIV and reduce reservoirs. This grant aims to enhance the delivery of antiretroviral drugs and biologics into CNS compartments while balancing therapeutic effect and toxicity. Collaborative research partnerships are encouraged for this opportunity. Closing date: Jan 07, 2021.
Opportunity ID: 308077
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-18-895 |
| Funding Opportunity Title: | CNS-Targeted Drug Delivery Strategies for HIV (R01 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.242 — Mental Health Research Grants |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Aug 08, 2018 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Jan 07, 2021 |
| Current Closing Date for Applications: | Jan 07, 2021 |
| Archive Date: | Feb 12, 2021 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Native American tribal governments (Federally recognized) Public and State controlled institutions of higher education Private institutions of higher education Independent school districts Others (see text field entitled “Additional Information on Eligibility” for clarification) For profit organizations other than small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses City or township governments Special district governments Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education County governments State governments |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this Funding Opportunity is to support studies with a focus on developing drug delivery strategies that target the Central Nervous System (CNS) for better suppression of Human Immunodeficiency Virus (HIV) and reservoir reduction. Applications are sought proposing multidisciplinary efforts to enhance delivery of antiretroviral (ARV) drugs and biologics into CNS compartments, maintaining a good balance between therapeutic effect and toxicity. Collaborative research partnerships are strongly encouraged but not required. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-18-895.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-E | Use for due dates on or before May 24, 2020 | PKG00244319 | Dec 07, 2018 | May 24, 2020 | View | |
| FORMS-F | Use for due dates on or after May 25, 2020 | PKG00259232 | Dec 07, 2018 | Jan 07, 2021 | View |
Package 1
Mandatory forms
308077 RR_SF424_2_0-2.0.pdf
308077 PHS398_CoverPageSupplement_4_0-4.0.pdf
308077 RR_OtherProjectInfo_1_4-1.4.pdf
308077 PerformanceSite_2_0-2.0.pdf
308077 RR_KeyPersonExpanded_2_0-2.0.pdf
308077 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
308077 RR_Budget_1_4-1.4.pdf
308077 RR_SubawardBudget30_1_4-1.4.pdf
308077 PHS398_ModularBudget_1_2-1.2.pdf
308077 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 2
Mandatory forms
308077 RR_SF424_2_0-2.0.pdf
308077 PHS398_CoverPageSupplement_5_0-5.0.pdf
308077 RR_OtherProjectInfo_1_4-1.4.pdf
308077 PerformanceSite_2_0-2.0.pdf
308077 RR_KeyPersonExpanded_2_0-2.0.pdf
308077 PHS398_ResearchPlan_4_0-4.0.pdf
308077 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
308077 RR_Budget_1_4-1.4.pdf
308077 RR_SubawardBudget30_1_4-1.4.pdf
308077 PHS398_ModularBudget_1_2-1.2.pdf
308077 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
